These studies are of direct clinical interest, since preclinical data indicates that TGF-β trap and IL-8 inhibitors rescue the myelofibrosis phenotype in animal models [11,25], and clinical trials with these drugs are currently under investigation [26]. The gene discussed is TGFB1; the disease is myelofibrosis.